Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio
- PMID: 8793803
- DOI: 10.1681/ASN.V76930
Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio
Abstract
The objective of this study was to determine the prevalence of stages of diabetic nephropathy, defined by the albumin/creatinine ratio (AC ratio) in repeated measurements in random urine samples. Over a 30-month interval, 1613 patients with Type I diabetes (IDDM) (aged 15 to 44 yr, IDDM duration 1 to 39 yr), and 218 healthy control subjects provided multiple urine specimens. AC ratios measured in urine samples taken 5 months apart were highly reproducible (Spearman r = 0.83). A criterion for the boundary between normoalbuminuria and microalbuminuria was obtained by searching for a cutpoint that optimized agreement between serial specimens on individuals. The result was lower in men than women: 17 as compared with 25 micrograms/mg. These two values corresponded to the 95th percentiles of the respective distributions of the AC ratio in healthy control subjects. Also these sex-specific cutpoints, when converted to albumin excretion rates, became almost equal: 30 and 31 micrograms/min. Microalbuminuria appeared early in the course of IDDM (6% of those with only 1 to 3 yr of diabetes) and then increased rapidly during two intervals, the first and third decades, before leveling off at 52%. By that time the cumulative risk of overt proteinuria had risen to 27%. Determinations of the AC ratio in random urine samples are easily obtained and are reliable indices of elevated urinary albumin excretion (microalbuminuria) in IDDM. The pattern of occurrence of microalbuminuria according to duration of IDDM suggests that there may be two subsets of diabetic nephropathy, one appearing early and the other late. Patients with microalbuminuria and 25 yr of postpubertal IDDM have low risk of progression to advanced diabetic nephropathy.
Similar articles
-
Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.Diabetes Care. 1993 Oct;16(10):1376-83. doi: 10.2337/diacare.16.10.1376. Diabetes Care. 1993. PMID: 8269796
-
The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.Ann Med. 1997 Oct;29(5):439-45. doi: 10.3109/07853899708999374. Ann Med. 1997. PMID: 9453292 Review.
-
Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?Diabetes. 1990 Jul;39(7):761-7. doi: 10.2337/diab.39.7.761. Diabetes. 1990. PMID: 2191882 Review.
-
Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus.Am J Kidney Dis. 1989 Apr;13(4):321-8. doi: 10.1016/s0272-6386(89)80039-3. Am J Kidney Dis. 1989. PMID: 2705450
-
[Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].Praxis (Bern 1994). 1995 Oct 31;84(44):1265-71. Praxis (Bern 1994). 1995. PMID: 7491450 Review. German.
Cited by
-
The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease.Kidney Int. 2012 Sep;82(5):589-97. doi: 10.1038/ki.2012.189. Epub 2012 May 23. Kidney Int. 2012. PMID: 22622493 Free PMC article.
-
New pharmacological treatments for improving renal outcomes in diabetes.Nat Rev Nephrol. 2010 Jun;6(6):371-80. doi: 10.1038/nrneph.2010.57. Epub 2010 May 4. Nat Rev Nephrol. 2010. PMID: 20440278 Review.
-
Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis.Liver Int. 2019 Aug;39(8):1535-1544. doi: 10.1111/liv.14125. Epub 2019 May 24. Liver Int. 2019. PMID: 31033142 Free PMC article.
-
Occurrence of microalbuminuria in young people with Type 1 diabetes: importance of age and diabetes duration.Diabet Med. 2010 May;27(5):532-7. doi: 10.1111/j.1464-5491.2010.02983.x. Diabet Med. 2010. PMID: 20536948 Free PMC article.
-
Cardiovascular outcomes associated with prescription of sodium-glucose co-transporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with diabetes and chronic kidney disease.Diabetes Obes Metab. 2022 May;24(5):928-937. doi: 10.1111/dom.14657. Epub 2022 Feb 16. Diabetes Obes Metab. 2022. PMID: 35118793 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical